Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics to prevent aspirin-induced small bowel injury
jRCTs031200395Completed
- Sponsor
- Japan Society for the Promotion of Science
- Start
- Apr 2021
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Trial of Lactobacillus gasseri OLL2716 in small bowel injury and Gastrointestinal microbiome disorder (GMD) (3 arms), sponsored by Japan Society for the Promotion of Science. Primary endpoint: Intestinal bacterial profile in the stool. Started Apr 2021; status: completed.
02
Drugs
Lactobacillus gasseri OLL2716
03
Conditions
small bowel injuryGastrointestinal microbiome disorder (GMD)
Beyond the preview
Go deeper on jRCTs031200395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200395.